Peptoid-based inhibitors of the protein arginine methyltransferase (PRMT) family
US11993556B1 · kind B1 · utility
1Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 16, 2021 |
| Grant date | May 28, 2024 |
| Priority date | — |
| Expiry date | Dec 3, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel peptoid compounds, compositions and methods of using the compounds and compositions to inhibit protein arginine methyltransferase (PRMT) and induce apoptosis in cancer cells are presented.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.